Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2024

Edition 3/2024

Edition 2/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes

J Hepatol. 2024;80(3):409–18

A phase 3 trial of seladelpar in primary biliary cholangitis

N Engl J Med. 2024;390(9):783–94

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

Hepatology. 2024;79(1):39–48

Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – A propensity score-matched intention-to-treat analysis

J Hepatol. 2024;80(1):99–108

Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry

Hepatology. 2024;79(3):538–50

Efficacy and safety of elafibranor in primary biliary cholangitis

N Engl J Med. 2024;390(9):795–805

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

J Hepatol. 2024;80(1):53–61

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumors

J Hepatol. 2024;80(3):431–42

Hepatocellular carcinoma surveillance patterns and outcomes in patients with cirrhosis

Clin Gastroenterol Hepatol. 2024;22(2):295–304.e2